Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

Trial Profile

Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs TL 118 (Primary) ; Antineoplastics
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Dec 2013 Planned initiation date changed from 1 Aug 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 04 Dec 2013 Planned end date changed from 1 Aug 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 14 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top